Journals / Turkish Neurosurgery / 2018 / Cilt: 28 - Sayı: 4

Targeting GRP78 as a Basis for Enhanced Glioma Cells Killing by Anti-TfR Antibody

Pages
538–543
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

SiRNA against the ER stress marker GRP78 produced a further sensitization of glioma cells to killing bythe anti-TfR antibody and/or Nimustine.CONCLUSION: Our results show the anti-TfR antibody triggers the ER stress response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Studies have illustrated that chemotherapeutic drugs induce endoplasmic reticulum (ER) stress in glioblastoma cells.
📊
Key Findings & Data:In ourprevious studies, it is clear that anti-transferrin receptor (anti-TfR) monoclonal antibody (mAB) 7579 enhanced anti-tumor effects ofchemotherapeutic drugs on human glioma cells in vitro.
💡
Conclusion & Impact:SiRNA against the ER stress marker GRP78 produced a further sensitization of glioma cells to killing bythe anti-TfR antibody and/or Nimustine.CONCLUSION: Our results show the anti-TfR antibody triggers the ER stress response.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: Studies have illustrated that chemotherapeutic drugs induce endoplasmic reticulum (ER) stress in glioblastoma cells. In ourprevious studies, it is clear that anti-transferrin receptor (anti-TfR) monoclonal antibody (mAB) 7579 enhanced anti-tumor effects ofchemotherapeutic drugs on human glioma cells in vitro. In our study, we therefore investigated how the anti-TfR antibody increasedER stress, alone or in combination with a chemotherapeutic drug.MATERIAL and METHODS: ER stress was detected after cells were treated with anti-TfR mAb and/or Nimustine by westernblot analysis. The colony survival and apoptosis of cells were detected after transfection with small interfering RNA (siRNA) andtreatment with anti-TfR mAb and/or Nimustine by labeling with methylene blue and FCM.RESULTS: The anti-TfR antibody combined with Nimustine could elevate expression of GRP78/BiP and CHOP/GADD153 andfurther increase ER stress. SiRNA against the ER stress marker GRP78 produced a further sensitization of glioma cells to killing bythe anti-TfR antibody and/or Nimustine.CONCLUSION: Our results show the anti-TfR antibody triggers the ER stress response. Furthermore, this anti-tumor effect isachieved via the siRNA against GRP78 for glioma cell growth and its survival. These results hold promise as a clinical approach togene therapy for malignant gliomas.

🔖

Cite This Article

WEN, X., CHEN, X., CHENG, X., WU, S. (2018). Targeting GRP78 as a Basis for Enhanced Glioma Cells Killing by Anti-TfR Antibody. Turkish Neurosurgery, Cilt: 28 - Sayı: 4, 538–543. https://ajindex.com/articles/405335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: A matter of life or death. Cell Death Differ 13:363-373, 2006
  2. Cho HY, Wang W, Jhaveri N, Torres S, Tseng J, Leong MN, Lee DJ, Goldkorn A, Xu T, Petasis NA, Louie SG, Schonthal AH, Hofman FM, Chen TC: Perillyl alcohol for the treatment of temozolomide-resistant gliomas. Mol Cancer Ther 11:2462- 2472, 2012
  3. Deng WG, Ruan KH, Du M, Saunders MA, Wu KK: Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts. Faseb J 15:2463-2470, 2001
  4. Ermakova SP, Kang BS, Choi BY, Choi HS, Schuster TF, Ma WY, Bode AM, Dong Z: (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res 66:9260-9269, 2006
  5. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY: Transferrin receptors in human tissues: Their distribution and possible clinical relevance. J Clin Pathol 36:539-545, 1983
  6. Hong Y, Yang J, Shen X, Zhu H, Sun X, Wen X, Bian J, Hu H, Yuan L, Tao J, Lei P, Shen G: Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells. Cancer Immunol Immunother 62:447- 454, 2012
  7. Jones DT, Trowbridge IS, Harris AL: Effects of transferrin receptor blockade on cancer cell proliferation and hypoxiainducible factor function and their differential regulation by ascorbate. Cancer Res 66:2749-2756, 2006
  8. Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schonthal AH: Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res 68:843-851, 2008
  9. Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT: Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 143:381-385, 1990 Lee AS: GRP78 induction in cancer: Therapeutic and prognostic implications. Cancer Res 67:3496-3499, 2007
  10. Lee HJ, Boado RJ, Braasch DA, Corey DR, Pardridge WM: Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. J Nucl Med 43:948-956, 2002
  11. Li J, Lee AS: Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6:45-54, 2006
  12. Oyadomari S, Mori M: R